Woodcock steps in at CDER as Galson departs
Drug center director Steven Galson was elevated to acting surgeon general.
His predecessor, FDA deputy commissioner and chief medical officer Janet Woodcock, who held the post for over a decade until 2005, has returned to the position on a temporary basis.
Galson's tenure was characterized by major public turbulence on the subordination of drug safety reviews to new drug-approval reviews, which he tried to reverse, the Vioxx and David Graham whistleblower controversy, and the uproar over the Plan B emergency contraceptive OTC switch.
FDA commissioner Andrew von Eschenbach told his employees in an e-mail that a national search for a permanent director for the drug center will begin “immediately.”